OIA
GNMX

OneDigital Investment Advisors’s Aevi Genomic Medicine Inc GNMX Stock Holding History

OneDigital Investment Advisors’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,555
Closed -$2K – 662
2019
Q4 		$2K Hold
15,555
– – ﹤0.01% 595
2019
Q3 		$2K Sell
15,555
-15,555
-50% -$2.81K ﹤0.01% 563
2019
Q2 		$4K Buy
31,110
+15,555
+100% +$3.15K ﹤0.01% 1092
2019
Q1 		$3K Hold
15,555
– – ﹤0.01% 1048
2018
Q4 		$11K Sell
15,555
-132
-0.8% -$147 ﹤0.01% 842
2018
Q3 		$19K Buy
15,687
+4,250
+37% +$4.75K ﹤0.01% 691
2018
Q2 		$13K Buy
11,437
+587
+5% +$892 ﹤0.01% 977
2018
Q1 		$22K Buy
10,850
+3,050
+39% +$5.73K ﹤0.01% 789
2017
Q4 		$9K Sell
7,800
-750
-9% -$1.02K ﹤0.01% 999
2017
Q3 		$11K Sell
8,550
-12,289
-59% -$15.7K ﹤0.01% 803
2017
Q2 		$28K Buy
+20,839
New +$30.1K 0.01% 639

OneDigital Investment Advisors's GNMX Position: Q1 2020 in Review

OneDigital Investment Advisors sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 15,555 shares — an estimated $2K sold.

OneDigital Investment Advisors first reported a position in GNMX in Q2 2017 and held it in 11 quarters. The position peaked at $28K in Q2 2017. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.

  • OneDigital Investment Advisors reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
  • OneDigital Investment Advisors sold 15,555 Aevi Genomic Medicine Inc shares in Q1 2020, an estimated $2K.
  • OneDigital Investment Advisors first reported a position in Aevi Genomic Medicine Inc in Q2 2017 and held it in 11 quarters.
  • OneDigital Investment Advisors's Aevi Genomic Medicine Inc position peaked at $28K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.

Based on OneDigital Investment Advisors's 13F filing for Q1 2020, filed 14 May 2020.